Carlie Tanner, MD, PhD

Director, Parkinson's Disease Research Education and Clinical Center
Professor
Neurology
Publications: 

Enhancing Clinical Information Display to Improve Patient Encounters: Human-Centered Design and Evaluation of the Parkinson Disease-BRIDGE Platform.

JMIR human factors

Brown EG, Schleimer E, Bledsoe IO, Rowles W, Miller NA, Sanders SJ, Rankin KP, Ostrem JL, Tanner CM, Bove R

Prevalence of parkinsonism and Parkinson disease in urban and rural populations from Latin America: A community based study.

Lancet Regional Health. Americas

Llibre-Guerra JJ, Prina M, Sosa AL, Acosta D, Jimenez-Velazquez IZ, Guerra M, Salas A, Llibre-Guerra JC, Valvuerdi A, Peeters G, Ziegemeier E, Acosta I, Tanner C, Juncos J, Llibre Rodriguez JJ

The epidemiology of cognitive function in Parkinson's disease.

Progress in brain research

Bock MA, Tanner CM

Predicting Parkinson's Disease and Its Pathology via Simple Clinical Variables.

Journal of Parkinson's disease

Karabayir I, Butler L, Goldman SM, Kamaleswaran R, Gunturkun F, Davis RL, Ross GW, Petrovitch H, Masaki K, Tanner CM, Tsivgoulis G, Alexandrov AV, Chinthala LK, Akbilgic O

Recruitment for Remote Decentralized Studies in Parkinson's Disease.

Journal of Parkinson's disease

Myers TL, Augustine EF, Baloga E, Daeschler M, Cannon P, Rowbotham H, Chanoff E, 23andMe Research Team, Jensen-Roberts S, Soto J, Holloway RG, Marras C, Tanner CM, Ray Dorsey E, Schneider RB

Sex-Related Longitudinal Change of Motor, Non-Motor, and Biological Features in Early Parkinson's Disease.

Journal of Parkinson's disease

Picillo M, LaFontant DE, Bressman S, Caspell-Garcia C, Coffey C, Cho HR, Burghardt EL, Dahodwala N, Sanders-Pullman R, Tanner CM, Amara AW, Parkinson’s Progression Markers Initiative

Surveying Global Availability of Parkinson's Disease Treatment.

Journal of Parkinson's disease

Goh ZHK, Cheong JLY, Marras C, Tanner CM, Kasten M, Korczyn AD, Chahine L, Lo R, Noyce AJ, Movement Disorders Society Epidemiology Study Group

Remote smartphone monitoring of Parkinson's disease and individual response to therapy.

Nature biotechnology

Omberg L, Chaibub Neto E, Perumal TM, Pratap A, Tediarjo A, Adams J, Bloem BR, Bot BM, Elson M, Goldman SM, Kellen MR, Kieburtz K, Klein A, Little MA, Schneider R, Suver C, Tarolli C, Tanner CM, Trister AD, Wilbanks J, Dorsey ER, Mangravite LM

Bad Air and Parkinson Disease-The Fog May Be Lifting.

JAMA neurology

Dorsey ER, Okun MS, Tanner CM

Caregiver-Reported Burden in RE-KINECT: Data From a Prospective Real-World Tardive Dyskinesia Screening Study.

Journal of the American Psychiatric Nurses Association

Cutler AJ, Caroff SN, Tanner CM, Shalhoub H, Lenderking WR, Pagé V, Franey E, Yonan C

Video-based Parkinson's disease assessments in a nationwide cohort of Fox Insight participants.

Clinical parkinsonism & related disorders

Myers TL, Tarolli CG, Adams JL, Barbano R, Cristina Gil-Díaz M, Spear KL, Lowell J, Daeschler M, Riley L, Amondikar N, Auinger P, Marras C, Tanner CM, Ray Dorsey E, Schneider RB

Genome-wide association studies of LRRK2 modifiers of Parkinson's disease.

Annals of neurology

Lai D, Alipanahi B, Fontanillas P, Schwantes-An TH, Aasly J, Alcalay RN, Beecham GW, Berg D, Bressman S, Brice A, Brockman K, Clark L, Cookson M, Das S, Van Deerlin V, Follett J, Farrer MJ, Trinh J, Gasser T, Goldwurm S, Gustavsson E, Klein C, Lang AE, Langston JW, Latourelle J, Lynch T, Marder K, Marras C, Martin ER, McLean CY, Mejia-Santana H, Molho E, Myers RH, Nuytemans K, Ozelius L, Payami H, Raymond D, Rogaeva E, Rogers MP, Ross OA, Samii A, Saunders-Pullman R, Schüle B, Schulte C, Scott WK, Tanner C, Tolosa E, Tomkins JE, Vilas D, Trojanowski JQ, 23andMe Research Team , Uitti R, Vance JM, Visanji NP, Wszolek ZK, Zabetian CP, Mirelman A, Giladi N, Orr Urtreger A, Cannon P, Fiske B, Foroud T

Longitudinal Analysis of Multiple Neurotransmitter Metabolites in Cerebrospinal Fluid in Early Parkinson's Disease.

Movement disorders : official journal of the Movement Disorder Society

Kremer T, Taylor KI, Siebourg-Polster J, Gerken T, Staempfli A, Czech C, Dukart J, Galasko D, Foroud T, Chahine LM, Coffey CS, Simuni T, Weintraub D, Seibyl J, Poston KL, Toga AW, Tanner CM, Marek K, Hutten SJ, Dziadek S, Trenkwalder C, Pagano G, Mollenhauer B

Current Knowledge on the Evolution of Care Partner Burden, Needs, and Coping in Parkinson's Disease.

Movement disorders clinical practice

Hulshoff MJ, Book E, Dahodwala N, Tanner CM, Robertson C, Marras C

The TOPAZ study: a home-based trial of zoledronic acid to prevent fractures in neurodegenerative parkinsonism.

NPJ Parkinson's disease

Tanner CM, Cummings SR, Schwarzschild MA, Brown EG, Dorsey ER, Espay AJ, Galifianakis NB, Goldman SM, Litvan I, Luthra N, McFarland NR, Mitchell KT, Standaert DG, Bauer DC, Greenspan SL, Beck JC, Lyles KW

Therapeutic Advances in Movement Disorders.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics

Tanner CM, Ostrem JL

Design of a virtual longitudinal observational study in Parkinson's disease (AT-HOME PD).

Annals of clinical and translational neurology

Schneider RB, Omberg L, Macklin EA, Daeschler M, Bataille L, Anthwal S, Myers TL, Baloga E, Duquette S, Snyder P, Amodeo K, Tarolli CG, Adams JL, Callahan KF, Gottesman J, Kopil CM, Lungu C, Ascherio A, Beck JC, Biglan K, Espay AJ, Tanner C, Oakes D, Shoulson I, Novak D, Kayson E, Ray Dorsey E, Mangravite L, Schwarzschild MA, Simuni T

Dopamine transporter imaging predicts clinically-defined a-synucleinopathy in REM sleep behavior disorder.

Annals of clinical and translational neurology

Chahine LM, Brumm MC, Caspell-Garcia C, Oertel W, Mollenhauer B, Amara A, Fernandez-Arcos A, Tolosa E, Simonet C, Hogl B, Videnovic A, Hutten SJ, Tanner C, Weintraub D, Burghardt E, Coffey C, Cho HR, Kieburtz K, Poston KL, Merchant K, Galasko D, Foroud T, Siderowf A, Marek K, Simuni T, Iranzo A

Differentiating Tardive Dyskinesia: A Video-Based Review of Antipsychotic-Induced Movement Disorders in Clinical Practice.

CNS spectrums

Hauser RA, Meyer JM, Factor SA, Comella CL, Tanner CM, Xavier RM, Caroff SN, Lundt L

Phenotype-Agnostic Molecular Subtyping of Neurodegenerative Disorders: The Cincinnati Cohort Biomarker Program (CCBP).

Frontiers in aging neuroscience

Sturchio A, Marsili L, Vizcarra JA, Dwivedi AK, Kauffman MA, Duker AP, Lu P, Pauciulo MW, Wissel BD, Hill EJ, Stecher B, Keeling EG, Vagal AS, Wang L, Haslam DB, Robson MJ, Tanner CM, Hagey DW, El Andaloussi S, Ezzat K, Fleming RMT, Lu LJ, Little MA, Espay AJ

Exploring the clinical burden of OFF periods in Parkinson disease.

The American journal of managed care

Tanner CM

The economic impact of OFF periods in Parkinson disease.

The American journal of managed care

Abeynayake I, Tanner CM

The impact of COVID-19 on access to Parkinson's disease medication.

Movement disorders : official journal of the Movement Disorder Society

Cheong JLY, Goh ZHK, Marras C, Tanner CM, Kasten M, Noyce AJ

Validation of Serum Neurofilament Light Chain as a Biomarker of Parkinson's Disease Progression.

Movement disorders : official journal of the Movement Disorder Society

Mollenhauer B, Dakna M, Kruse N, Galasko D, Foroud T, Zetterberg H, Schade S, Gera RG, Wang W, Gao F, Frasier M, Chahine LM, Coffey CS, Singleton AB, Simuni T, Weintraub D, Seibyl J, Toga AW, Tanner CM, Kieburtz K, Marek K, Siderowf A, Cedarbaum JM, Hutten SJ, Trenkwalder C, Graham D

Nonsteroidal Anti-Inflammatory Use and LRRK2 Parkinson's Disease Penetrance.

Movement disorders : official journal of the Movement Disorder Society

San Luciano M, Tanner CM, Meng C, Marras C, Goldman SM, Lang AE, Tolosa E, Schüle B, Langston JW, Brice A, Corvol JC, Goldwurm S, Klein C, Brockman S, Berg D, Brockmann K, Ferreira JJ, Tazir M, Mellick GD, Sue CM, Hasegawa K, Tan EK, Bressman S, Saunders-Pullman R

Current and projected future economic burden of Parkinson's disease in the U.S.

NPJ Parkinson's disease

Yang W, Hamilton JL, Kopil C, Beck JC, Tanner CM, Albin RL, Ray Dorsey E, Dahodwala N, Cintina I, Hogan P, Thompson T

Electrocardiographic changes predate Parkinson's disease onset.

Scientific reports

Akbilgic O, Kamaleswaran R, Mohammed A, Ross GW, Masaki K, Petrovitch H, Tanner CM, Davis RL, Goldman SM

Evolution of Alzheimer's Disease Cerebrospinal Fluid Biomarkers in Early Parkinson's Disease.

Annals of neurology

Irwin DJ, Fedler J, Coffey CS, Caspell-Garcia C, Kang JH, Simuni T, Foroud T, Toga AW, Tanner CM, Kieburtz K, Chahine LM, Reimer A, Hutten S, Weintraub D, Mollenhauer B, Galasko DR, Siderowf A, Marek K, Trojanowski JQ, Shaw LM

Remote telemedicine evaluation of deep brain stimulation candidacy: Retrospective cohort analysis.

Neurology. Clinical practice

Witek N, Heath SL, Ouyang B, Tanner CM, Galifianakis NB

Reply to: Diagnostic Delay in Cervical Dystonia-Dystonia With Antecedent ET?

Movement disorders : official journal of the Movement Disorder Society

LaHue SC, Tanner CM

RE-KINECT: A Prospective Study of the Presence and Healthcare Burden of Tardive Dyskinesia in Clinical Practice Settings.

Journal of clinical psychopharmacology

Caroff SN, Yeomans K, Lenderking WR, Cutler AJ, Tanner CM, Shalhoub H, Pagé V, Chen J, Franey E, Yonan C

Fox Insight collects online, longitudinal patient-reported outcomes and genetic data on Parkinson's disease.

Scientific data

Smolensky L, Amondikar N, Crawford K, Neu S, Kopil CM, Daeschler M, Riley L, Brown E, Toga AW, Tanner C

Clinical and Dopamine Transporter Imaging Characteristics of Leucine- Rich Repeat Kinase 2 (LRRK2) and Glucosylceramidase Beta (GBA) Parkinson's Disease Participants in the Parkinson's Progression Markers Initiative: A Cross-Sectional Study.

Movement disorders : official journal of the Movement Disorder Society

Simuni T, Brumm MC, Uribe L, Caspell-Garcia C, Coffey CS, Siderowf A, Alcalay R, Trojanowski JQ, Shaw LM, Seibyl J, Singleton A, Toga AW, Galasko D, Foroud T, Nudelman K, Tosun-Turgut D, Poston K, Weintraub D, Mollenhauer B, Tanner CM, Kieburtz K, Chahine LM, Reimer A, Hutten S, Bressman S, Marek K

ß-adrenoreceptors and the risk of Parkinson's disease.

The Lancet. Neurology

Hopfner F, Höglinger GU, Kuhlenbäumer G, Pottegård A, Wod M, Christensen K, Tanner CM, Deuschl G

A Virtual Cohort Study of Individuals at Genetic Risk for Parkinson's Disease: Study Protocol and Design.

Journal of Parkinson's disease

Schneider RB, Myers TL, Rowbotham HM, Luff MK, Amodeo K, Sharma S, Wilson R, Jensen-Roberts S, Auinger P, McDermott MP, Alcalay RN, Biglan K, Kinel D, Tanner C, Winter-Evans R, Augustine EF, Cannon P, Holloway RG, Dorsey ER

Comparison of an Online-Only Parkinson's Disease Research Cohort to Cohorts Assessed In Person.

Journal of Parkinson's disease

Chahine LM, Chin I, Caspell-Garcia C, Standaert DG, Brown E, Smolensky L, Arnedo V, Daeschler D, Riley L, Korell M, Dobkin R, Amondikar N, Gradinscak S, Shoulson I, Dean M, Kwok K, Cannon P, Marek K, Kopil C, Tanner CM, Marrason C

EASE LID 2: A 2-Year Open-Label Trial of Gocovri (Amantadine) Extended Release for Dyskinesia in Parkinson's Disease.

Journal of Parkinson's disease

Tanner CM, Pahwa R, Hauser RA, Oertel WH, Isaacson SH, Jankovic J, Johnson R, Chernick D, Hubble J

Innovative Recruitment Strategies to Increase Diversity of Participation in Parkinson's Disease Research: The Fox Insight Cohort Experience.

Journal of Parkinson's disease

Dobkin RD, Amondikar N, Kopil C, Caspell-Garcia C, Brown E, Chahine LM, Marras C, Dahodwala N, Mantri S, Standaert DG, Dean M, Shoulson I, Marek K, Katz A, Korell M, Riley L, Tanner CM

The Effect of the COVID-19 Pandemic on People with Parkinson's Disease.

Journal of Parkinson's disease

Brown EG, Chahine LM, Goldman SM, Korell M, Mann E, Kinel DR, Arnedo V, Marek KL, Tanner CM

Translation, Validation, Diagnostic Accuracy, and Reliability of Screening Questionnaire for Parkinsonism in Three African Countries.

Journal of Parkinson's disease

Shalash A, Okubadejo NU, Doumbe J, Ojo OO, Hamid E, Kuate C, Calvo S, Helmi A, Agabi OP, Essam M, Aguado L, Elrassas H, Roushdy T, Tanner CM, Cubo E

Cervical dystonia incidence and diagnostic delay in a multiethnic population.

Movement disorders : official journal of the Movement Disorder Society

LaHue SC, Albers K, Goldman S, Lo R, Gu Z, Leimpeter A, Fross R, Comyns K, Marras C, de Kleijn A, Smit R, Katz M, Ozelius LJ, Bressman S, Saunders-Pullman R, Comella C, Klingman J, Nelson LM, Van Den Eeden SK, Tanner CM

A Phase 3, 1-Year, Open-Label Trial of Valbenazine in Adults With Tardive Dyskinesia.

Journal of clinical psychopharmacology

Marder SR, Singer C, Lindenmayer JP, Tanner CM, Comella CL, Verghese C, Jimenez R, Liang GS, Burke J, O'Brien CF

Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study.

The Lancet. Neurology

Simuni T, Uribe L, Cho HR, Caspell-Garcia C, Coffey CS, Siderowf A, Trojanowski JQ, Shaw LM, Seibyl J, Singleton A, Toga AW, Galasko D, Foroud T, Tosun D, Poston K, Weintraub D, Mollenhauer B, Tanner CM, Kieburtz K, Chahine LM, Reimer A, Hutten SJ, Bressman S, Marek K

Excessive daytime sleepiness and topographic expansion of Lewy pathology.

Neurology

Abbott RD, Ross GW, Duda JE, Shin C, Uyehara-Lock JH, Masaki KH, Launer LJ, White LR, Tanner CM, Petrovitch H

Parkinson Disease Epidemiology, Pathology, Genetics, and Pathophysiology.

Clinics in geriatric medicine

Simon DK, Tanner CM, Brundin P

Longitudinal analyses of cerebrospinal fluid a-Synuclein in prodromal and early Parkinson's disease.

Movement disorders : official journal of the Movement Disorder Society

Mollenhauer B, Caspell-Garcia CJ, Coffey CS, Taylor P, Singleton A, Shaw LM, Trojanowski JQ, Frasier M, Simuni T, Iranzo A, Oertel W, Siderowf A, Weintraub D, Seibyl J, Toga AW, Tanner CM, Kieburtz K, Chahine LM, Marek K, Galasko D

The NAS-NRC Twin Registry and Duke Twins Study of Memory in Aging: An Update.

Twin research and human genetics : the official journal of the International Society for Twin Studies

Gatz M, Plassman BL, Tanner CM, Goldman SM, Swan GE, Chanti-Ketterl M, Walters EE, Butler DA

Rotenone and Parkinson's disease: reduced sensitivity in females.

Toxicological sciences : an official journal of the Society of Toxicology

Goldman SM, Tanner CM

A specific amino acid motif of HLA-DRB1 mediates risk and interacts with smoking history in Parkinson's disease.

Proceedings of the National Academy of Sciences of the United States of America

Hollenbach JA, Norman PJ, Creary LE, Damotte V, Montero-Martin G, Caillier S, Anderson KM, Misra MK, Nemat-Gorgani N, Osoegawa K, Santaniello A, Renschen A, Marin WM, Dandekar R, Parham P, Tanner CM, Hauser SL, Fernandez-Viña M, Oksenberg JR

Concordance for Parkinson's disease in twins: A 20-year update.

Annals of neurology

Goldman SM, Marek K, Ottman R, Meng C, Comyns K, Chan P, Ma J, Marras C, Langston JW, Ross GW, Tanner CM

Revisiting protein aggregation as pathogenic in sporadic Parkinson and Alzheimer diseases.

Neurology

Espay AJ, Vizcarra JA, Marsili L, Lang AE, Simon DK, Merola A, Josephs KA, Fasano A, Morgante F, Savica R, Greenamyre JT, Cambi F, Yamasaki TR, Tanner CM, Gan-Or Z, Litvan I, Mata IF, Zabetian CP, Brundin P, Fernandez HH, Standaert DG, Kauffman MA, Schwarzschild MA, Sardi SP, Sherer T, Perry G, Leverenz JB

Feasibility and safety of lumbar puncture in the Parkinson's disease research participants: Parkinson's Progression Marker Initiative (PPMI).

Parkinsonism & related disorders

Prakash N, Caspell-Garcia C, Coffey C, Siderowf A, Tanner CM, Kieburtz K, Mollenhauer B, Galasko D, Merchant K, Foroud T, Chahine LM, Weintraub D, Casaceli C, Dorsey R, Wilson R, Herzog M, Daegele N, Arnedo V, Frasier M, Sherer T, Marek K, Simuni T

Predicting Progression in Parkinson's Disease Using Baseline and 1-Year Change Measures.

Journal of Parkinson's disease

Chahine LM, Siderowf A, Barnes J, Seedorff N, Caspell-Garcia C, Simuni T, Coffey CS, Galasko D, Mollenhauer B, Arnedo V, Daegele N, Frasier M, Tanner C, Kieburtz K, Marek K

Association of brain heptachlor epoxide and other organochlorine compounds with lewy pathology.

Movement disorders : official journal of the Movement Disorder Society

Ross GW, Abbott RD, Petrovitch H, Duda JE, Tanner CM, Zarow C, Uyehara-Lock JH, Masaki KH, Launer LJ, Studabaker WB, White LR

Reply to "Studying reproducibility of data-driven Parkinson's disease subtypes".

Parkinsonism & related disorders

Mestre TA, Eberly S, Tanner C, Grimes D, Lang AE, Oakes D, Marras C

The Parkinson's progression markers initiative (PPMI) - establishing a PD biomarker cohort.

Annals of clinical and translational neurology

Marek K, Chowdhury S, Siderowf A, Lasch S, Coffey CS, Caspell-Garcia C, Simuni T, Jennings D, Tanner CM, Trojanowski JQ, Shaw LM, Seibyl J, Schuff N, Singleton A, Kieburtz K, Toga AW, Mollenhauer B, Galasko D, Chahine LM, Weintraub D, Foroud T, Tosun-Turgut D, Poston K, Arnedo V, Frasier M, Sherer T

Occupational exposures and parkinsonism among Shanghai women textile workers.

American journal of industrial medicine

Checkoway H, Ilango S, Li W, Ray RM, Tanner CM, Hu SC, Wang X, Nielsen S, Gao DL, Thomas DB

Mendel and urate: Acid test or random noise?

Parkinsonism & related disorders

Brown EG, Goldman SM, Tanner CM

Reproducibility of data-driven Parkinson's disease subtypes for clinical research.

Parkinsonism & related disorders

Mestre TA, Eberly S, Tanner C, Grimes D, Lang AE, Oakes D, Marras C

Longitudinal change of clinical and biological measures in early Parkinson's disease: Parkinson's progression markers initiative cohort.

Movement disorders : official journal of the Movement Disorder Society

Simuni T, Siderowf A, Lasch S, Coffey CS, Caspell-Garcia C, Jennings D, Tanner CM, Trojanowski JQ, Shaw LM, Seibyl J, Schuff N, Singleton A, Kieburtz K, Toga AW, Mollenhauer B, Galasko D, Chahine LM, Weintraub D, Foroud T, Tosun D, Poston K, Arnedo V, Frasier M, Sherer T, Chowdhury S, Marek K

Telemedicine Use for Movement Disorders: A Global Survey.

Telemedicine journal and e-health : the official journal of the American Telemedicine Association

Hassan A, Dorsey ER, Goetz CG, Bloem BR, Guttman M, Tanner CM, Mari Z, Pantelyat A, Galifianakis NB, Bajwa JA, Gatto EM, Cubo E

Parkinson's Patients with Dyskinesia Switched from Immediate Release Amantadine to Open-label ADS-5102.

Movement disorders clinical practice

Isaacson SH, Fahn S, Pahwa R, Tanner CM, Espay AJ, Trenkwalder C, Adler CH, Patni R, Johnson R

Selected health and lifestyle factors, cytosine-adenine-guanine status, and phenoconversion in Huntington's disease.

Movement disorders : official journal of the Movement Disorder Society

Tanner C, Marder K, Eberly S, Biglan K, Oakes D, Shoulson I

Baseline prevalence and longitudinal evolution of non-motor symptoms in early Parkinson's disease: the PPMI cohort.

Journal of neurology, neurosurgery, and psychiatry

Simuni T, Caspell-Garcia C, Coffey CS, Weintraub D, Mollenhauer B, Lasch S, Tanner CM, Jennings D, Kieburtz K, Chahine LM, Marek K

Lessons Learned From Past Gene-Environment Interaction Successes.

American journal of epidemiology

Ritz BR, Chatterjee N, Garcia-Closas M, Gauderman WJ, Pierce BL, Kraft P, Tanner CM, Mechanic LE, McAllister K

Randomized, placebo-controlled trial of ADS-5102 (amantadine) extended-release capsules for levodopa-induced dyskinesia in Parkinson's disease (EASE LID 3).

Movement disorders : official journal of the Movement Disorder Society

Oertel W, Eggert K, Pahwa R, Tanner CM, Hauser RA, Trenkwalder C, Ehret R, Azulay JP, Isaacson S, Felt L, Stempien MJ

National randomized controlled trial of virtual house calls for Parkinson disease.

Neurology

Beck CA, Beran DB, Biglan KM, Boyd CM, Dorsey ER, Schmidt PN, Simone R, Willis AW, Galifianakis NB, Katz M, Tanner CM, Dodenhoff K, Aldred J, Carter J, Fraser A, Jimenez-Shahed J, Hunter C, Spindler M, Reichwein S, Mari Z, Dunlop B, Morgan JC, McLane D, Hickey P, Gauger L, Richard IH, Mejia NI, Bwala G, Nance M, Shih LC, Singer C, Vargas-Parra S, Zadikoff C, Okon N, Feigin A, Ayan J, Vaughan C, Pahwa R, Dhall R, Hassan A, DeMello S, Riggare SS, Wicks P, Achey MA, Elson MJ, Goldenthal S, Keenan HT, Korn R, Schwarz H, Sharma S, Stevenson EA, Zhu W

ADS-5102 (Amantadine) Extended-Release Capsules for Levodopa-Induced Dyskinesia in Parkinson Disease (EASE LID Study): A Randomized Clinical Trial.

JAMA neurology

Pahwa R, Tanner CM, Hauser RA, Isaacson SH, Nausieda PA, Truong DD, Agarwal P, Hull KL, Lyons KE, Johnson R, Stempien MJ

Virtual visits for Parkinson disease: A multicenter noncontrolled cohort.

Neurology. Clinical practice

Korn RE, Wagle Shukla A, Katz M, Keenan HT, Goldenthal S, Auinger P, Zhu W, Dodge M, Rizer K, Achey MA, Byrd E, Barbano R, Richard I, Andrzejewski KL, Schwarz HB, Dorsey ER, Biglan KM, Kang G, Kanchana S, Rodriguez R, Tanner CM, Galifianakis NB

Prediction of cognition in Parkinson's disease with a clinical-genetic score: a longitudinal analysis of nine cohorts.

The Lancet. Neurology

Liu G, Locascio JJ, Corvol JC, Boot B, Liao Z, Page K, Franco D, Burke K, Jansen IE, Trisini-Lipsanopoulos A, Winder-Rhodes S, Tanner CM, Lang AE, Eberly S, Elbaz A, Brice A, Mangone G, Ravina B, Shoulson I, Cormier-Dequaire F, Heutink P, van Hilten JJ, Barker RA, Williams-Gray CH, Marinus J, Scherzer CR

A Bayesian mathematical model of motor and cognitive outcomes in Parkinson's disease.

PloS one

Hayete B, Wuest D, Laramie J, McDonagh P, Church B, Eberly S, Lang A, Marek K, Runge K, Shoulson I, Singleton A, Tanner C, Khalil I, Verma A, Ravina B

Parkinson disease.

Nature reviews. Disease primers

Poewe W, Seppi K, Tanner CM, Halliday GM, Brundin P, Volkmann J, Schrag AE, Lang AE

Biomarker-driven phenotyping in Parkinson's disease: A translational missing link in disease-modifying clinical trials.

Movement disorders : official journal of the Movement Disorder Society

Espay AJ, Schwarzschild MA, Tanner CM, Fernandez HH, Simon DK, Leverenz JB, Merola A, Chen-Plotkin A, Brundin P, Kauffman MA, Erro R, Kieburtz K, Woo D, Macklin EA, Standaert DG, Lang AE

Caffeine, creatine, GRIN2A and Parkinson's disease progression.

Journal of the neurological sciences

Simon DK, Wu C, Tilley BC, Lohmann K, Klein C, Payami H, Wills AM, Aminoff MJ, Bainbridge J, Dewey R, Hauser RA, Schaake S, Schneider JS, Sharma S, Singer C, Tanner CM, Truong D, Wei P, Wong PS, Yang T

Heart rate variability in leucine-rich repeat kinase 2-associated Parkinson's disease.

Movement disorders : official journal of the Movement Disorder Society

Visanji NP, Bhudhikanok GS, Mestre TA, Ghate T, Udupa K, AlDakheel A, Connolly BS, Gasca-Salas C, Kern DS, Jain J, Slow EJ, Faust-Socher A, Kim S, Azhu Valappil R, Kausar F, Rogaeva E, William Langston J, Tanner CM, Schüle B, Lang AE, Goldman SM, Marras C

ADS-5102 (Amantadine) Extended-Release Capsules for Levodopa-Induced Dyskinesia in Parkinson's Disease (EASE LID 2 Study): Interim Results of an Open-Label Safety Study.

Journal of Parkinson's disease

Hauser RA, Pahwa R, Tanner CM, Oertel W, Isaacson SH, Johnson R, Felt L, Stempien MJ

Knowledge gaps and research recommendations for essential tremor.

Parkinsonism & related disorders

Hopfner F, Haubenberger D, Galpern WR, Gwinn K, Van't Veer A, White S, Bhatia K, Adler CH, Eidelberg D, Ondo W, Stebbins GT, Tanner CM, Helmich RC, Lenz FA, Sillitoe RV, Vaillancourt D, Vitek JL, Louis ED, Shill HA, Frosch MP, Foroud T, Kuhlenbäumer G, Singleton A, Testa CM, Hallett M, Elble R, Deuschl G

The best medicine? The influence of physical activity and inactivity on Parkinson's disease.

Movement disorders : official journal of the Movement Disorder Society

LaHue SC, Comella CL, Tanner CM

Problematic Mobile Gaming in Parkinson's Disease: An Impulse Control Disorder for the Smartphone.

Movement disorders clinical practice

Galifianakis NB, Byrd EA, Ostrem JL, Tanner CM, Racine CA

Predictors of time to initiation of symptomatic therapy in early Parkinson's disease.

Annals of clinical and translational neurology

Simuni T, Long JD, Caspell-Garcia C, Coffey CS, Lasch S, Tanner CM, Jennings D, Kieburtz KD, Marek K

How stable are Parkinson's disease subtypes in de novo patients: Analysis of the PPMI cohort?

Parkinsonism & related disorders

Simuni T, Caspell-Garcia C, Coffey C, Lasch S, Tanner C, Marek K

CSF biomarkers associated with disease heterogeneity in early Parkinson's disease: the Parkinson's Progression Markers Initiative study.

Acta neuropathologica

Kang JH, Mollenhauer B, Coffey CS, Toledo JB, Weintraub D, Galasko DR, Irwin DJ, Van Deerlin V, Chen-Plotkin AS, Caspell-Garcia C, Waligórska T, Taylor P, Shah N, Pan S, Zero P, Frasier M, Marek K, Kieburtz K, Jennings D, Tanner CM, Simuni T, Singleton A, Toga AW, Chowdhury S, Trojanowski JQ, Shaw LM

National Randomized Controlled Trial of Virtual House Calls for People with Parkinson's Disease: Interest and Barriers.

Telemedicine journal and e-health : the official journal of the American Telemedicine Association

Dorsey ER, Achey MA, Beck CA, Beran DB, Biglan KM, Boyd CM, Schmidt PN, Simone R, Willis AW, Galifianakis NB, Katz M, Tanner CM, Dodenhoff K, Ziman N, Aldred J, Carter J, Jimenez-Shahed J, Hunter C, Spindler M, Mari Z, Morgan JC, McLane D, Hickey P, Gauger L, Richard IH, Bull MT, Mejia NI, Bwala G, Nance M, Shih L, Anderson L, Singer C, Zadikoff C, Okon N, Feigin A, Ayan J, Vaughan C, Pahwa R, Cooper J, Webb S, Dhall R, Hassan A, Weis D, DeMello S, Riggare SS, Wicks P, Smith J, Keenan HT, Korn R, Schwarz H, Sharma S, Stevenson EA, Zhu W

Early Clinical Predictors of Treatment-Resistant and Functional Outcomes in Parkinson's Disease.

Movement disorders clinical practice

Kurlan R, Ravina B, Eberly S, Lang AE, Tanner CM, Marek K, Marder K, Beck J, Elliott R, Oakes D, Shoulson I

Midlife milk consumption and substantia nigra neuron density at death.

Neurology

Abbott RD, Ross GW, Petrovitch H, Masaki KH, Launer LJ, Nelson JS, White LR, Tanner CM

Caffeine and Progression of Parkinson Disease: A Deleterious Interaction With Creatine.

Clinical neuropharmacology

Simon DK, Wu C, Tilley BC, Wills AM, Aminoff MJ, Bainbridge J, Hauser RA, Schneider JS, Sharma S, Singer C, Tanner CM, Truong D, Wong PS

Parkinson's disease research in a prospective cohort in China.

Parkinsonism & related disorders

Chen H, Ding D, Wang J, Zhao Q, Meng H, Li H, Gao YT, Shu XO, Tanner CM, Hong Z, Yang G

Diffusion imaging of nigral alterations in early Parkinson's disease with dopaminergic deficits.

Movement disorders : official journal of the Movement Disorder Society

Schuff N, Wu IW, Buckley S, Foster ED, Coffey CS, Gitelman DR, Mendick S, Seibyl J, Simuni T, Zhang Y, Jankovic J, Hunter C, Tanner CM, Rees L, Factor S, Berg D, Wurster I, Gauss K, Sprenger F, Seppi K, Poewe W, Mollenhauer B, Knake S, Mari Z, McCoy A, Ranola M, Marek K

Risk of Cardiovascular Disease Associated with a Restless Legs Syndrome Diagnosis in a Retrospective Cohort Study from Kaiser Permanente Northern California.

Sleep

Van Den Eeden SK, Albers KB, Davidson JE, Kushida CA, Leimpeter AD, Nelson LM, Popat R, Tanner CM, Bibeau K, Quesenberry CP

Natural history of multiple system atrophy in the USA: a prospective cohort study.

The Lancet. Neurology

Low PA, Reich SG, Jankovic J, Shults CW, Stern MB, Novak P, Tanner CM, Gilman S, Marshall FJ, Wooten F, Racette B, Chelimsky T, Singer W, Sletten DM, Sandroni P, Mandrekar J

Associations of Ozone and PM2.5 Concentrations With Parkinson's Disease Among Participants in the Agricultural Health Study.

Journal of occupational and environmental medicine

Kirrane EF, Bowman C, Davis JA, Hoppin JA, Blair A, Chen H, Patel MM, Sandler DP, Tanner CM, Vinikoor-Imler L, Ward MH, Luben TJ, Kamel F

Traumatic brain injury in later life increases risk for Parkinson disease.

Annals of neurology

Gardner RC, Burke JF, Nettiksimmons J, Goldman S, Tanner CM, Yaffe K

Variants associated with Gaucher disease in multiple system atrophy.

Annals of clinical and translational neurology

Mitsui J, Matsukawa T, Sasaki H, Yabe I, Matsushima M, Dürr A, Brice A, Takashima H, Kikuchi A, Aoki M, Ishiura H, Yasuda T, Date H, Ahsan B, Iwata A, Goto J, Ichikawa Y, Nakahara Y, Momose Y, Takahashi Y, Hara K, Kakita A, Yamada M, Takahashi H, Onodera O, Nishizawa M, Watanabe H, Ito M, Sobue G, Ishikawa K, Mizusawa H, Kanai K, Hattori T, Kuwabara S, Arai K, Koyano S, Kuroiwa Y, Hasegawa K, Yuasa T, Yasui K, Nakashima K, Ito H, Izumi Y, Kaji R, Kato T, Kusunoki S, Osaki Y, Horiuchi M, Kondo T, Murayama S, Hattori N, Yamamoto M, Murata M, Satake W, Toda T, Filla A, Klockgether T, Wüllner U, Nicholson G, Gilman S, Tanner CM, Kukull WA, Stern MB, Lee VM, Trojanowski JQ, Masliah E, Low PA, Sandroni P, Ozelius LJ, Foroud T, Tsuji S

Amantadine extended release for levodopa-induced dyskinesia in Parkinson's disease (EASED Study).

Movement disorders : official journal of the Movement Disorder Society

Pahwa R, Tanner CM, Hauser RA, Sethi K, Isaacson S, Truong D, Struck L, Ruby AE, McClure NL, Went GT, Stempien MJ

When brawn benefits brain: physical activity and Parkinson's disease risk.

Brain : a journal of neurology

Tanner CM, Comella CL

Protective glove use and hygiene habits modify the associations of specific pesticides with Parkinson's disease.

Environment international

Furlong M, Tanner CM, Goldman SM, Bhudhikanok GS, Blair A, Chade A, Comyns K, Hoppin JA, Kasten M, Korell M, Langston JW, Marras C, Meng C, Richards M, Ross GW, Umbach DM, Sandler DP, Kamel F

The relationship between obsessive-compulsive symptoms and PARKIN genotype: The CORE-PD study.

Movement disorders : official journal of the Movement Disorder Society

Sharp ME, Caccappolo E, Mejia-Santana H, Tang MX, Rosado L, Orbe Reilly M, Ruiz D, Louis ED, Comella C, Nance M, Bressman S, Scott WK, Tanner C, Waters C, Fahn S, Cote L, Ford B, Rezak M, Novak K, Friedman JH, Pfeiffer R, Payami H, Molho E, Factor SA, Nutt J, Serrano C, Arroyo M, Pauciulo MW, Nichols WC, Clark LN, Alcalay RN, Marder KS

Mendelian randomization of serum urate and parkinson disease progression.

Annals of neurology

Simon KC, Eberly S, Gao X, Oakes D, Tanner CM, Shoulson I, Fahn S, Schwarzschild MA, Ascherio A

Michael J. Fox Foundation LRRK2 Consortium: geographical differences in returning genetic research data to study participants.

Genetics in medicine : official journal of the American College of Medical Genetics

Alcalay RN, Aasly J, Berg D, Bressman S, Brice A, Brockmann K, Chan P, Clark L, Cormier F, Corvol JC, Durr A, Facheris M, Farrer M, Foroud TM, Gasser T, Giladi N, Halter C, Lang A, Langston JW, Marras C, Marti-Masso JF, Ruiz Martinez J, Mejia-Santana H, Mirelman A, Pont-Sunyer C, Orr-Urtreger A, Raymond D, Saunders-Pullman R, Schüle B, Tanner C, Tolosa E, Urkowitz A, Vilas D, Wise A, Marder K

The disease intersection of susceptibility and exposure: chemical exposures and neurodegenerative disease risk.

Alzheimer's & dementia : the journal of the Alzheimer's Association

Tanner CM, Goldman SM, Ross GW, Grate SJ

Peptidoglycan recognition protein genes and risk of Parkinson's disease.

Movement disorders : official journal of the Movement Disorder Society

Goldman SM, Kamel F, Ross GW, Jewell SA, Marras C, Hoppin JA, Umbach DM, Bhudhikanok GS, Meng C, Korell M, Comyns K, Hauser RA, Jankovic J, Factor SA, Bressman S, Lyons KE, Sandler DP, Langston JW, Tanner CM

The past, present, and future of telemedicine for Parkinson's disease.

Movement disorders : official journal of the Movement Disorder Society

Achey M, Aldred JL, Aljehani N, Bloem BR, Biglan KM, Chan P, Cubo E, Dorsey ER, Goetz CG, Guttman M, Hassan A, Khandhar SM, Mari Z, Spindler M, Tanner CM, van den Haak P, Walker R, Wilkinson JR

A practical approach to remote longitudinal follow-up of Parkinson's disease: the FOUND study.

Movement disorders : official journal of the Movement Disorder Society

Tanner CM, Meng CC, Ravina B, Lang A, Kurlan R, Marek K, Oakes D, Seibyl J, Flagg E, Gauger L, Guest DD, Goetz CG, Kieburtz K, DiEuliis D, Fahn S, Elliott RA, Shoulson I

Cognitive and motor function in long-duration PARKIN-associated Parkinson disease.

JAMA neurology

Alcalay RN, Caccappolo E, Mejia-Santana H, Tang MX, Rosado L, Orbe Reilly M, Ruiz D, Louis ED, Comella CL, Nance MA, Bressman SB, Scott WK, Tanner CM, Mickel SF, Waters CH, Fahn S, Cote LJ, Frucht SJ, Ford B, Rezak M, Novak KE, Friedman JH, Pfeiffer RF, Marsh L, Hiner B, Payami H, Molho E, Factor SA, Nutt JG, Serrano C, Arroyo M, Ottman R, Pauciulo MW, Nichols WC, Clark LN, Marder KS

Relationship of Mediterranean diet and caloric intake to phenoconversion in Huntington disease.

JAMA neurology

Marder K, Gu Y, Eberly S, Tanner CM, Scarmeas N, Oakes D, Shoulson I

Movement disorder society unified Parkinson disease rating scale experiences in daily living: longitudinal changes and correlation with other assessments.

Movement disorders : official journal of the Movement Disorder Society

Lang AE, Eberly S, Goetz CG, Stebbins G, Oakes D, Marek K, Ravina B, Tanner CM, Shoulson I

Association of cerebrospinal fluid ß-amyloid 1-42, T-tau, P-tau181, and a-synuclein levels with clinical features of drug-naive patients with early Parkinson disease.

JAMA neurology

Kang JH, Irwin DJ, Chen-Plotkin AS, Siderowf A, Caspell C, Coffey CS, Waligórska T, Taylor P, Pan S, Frasier M, Marek K, Kieburtz K, Jennings D, Simuni T, Tanner CM, Singleton A, Toga AW, Chowdhury S, Mollenhauer B, Trojanowski JQ, Shaw LM

Dietary fat intake, pesticide use, and Parkinson's disease.

Parkinsonism & related disorders

Kamel F, Goldman SM, Umbach DM, Chen H, Richardson G, Barber MR, Meng C, Marras C, Korell M, Kasten M, Hoppin JA, Comyns K, Chade A, Blair A, Bhudhikanok GS, Webster Ross G, William Langston J, Sandler DP, Tanner CM

Research on the premotor symptoms of Parkinson's disease: clinical and etiological implications.

Environmental health perspectives

Chen H, Burton EA, Ross GW, Huang X, Savica R, Abbott RD, Ascherio A, Caviness JN, Gao X, Gray KA, Hong JS, Kamel F, Jennings D, Kirshner A, Lawler C, Liu R, Miller GW, Nussbaum R, Peddada SD, Rick AC, Ritz B, Siderowf AD, Tanner CM, Tröster AI, Zhang J

Alpha-synuclein: one key opens many locks.

Movement disorders : official journal of the Movement Disorder Society

Tanner CM

A second honeymoon for Parkinson's disease?

The New England journal of medicine

Tanner CM

Which dyskinesia scale best detects treatment response?

Movement disorders : official journal of the Movement Disorder Society

Goetz CG, Stebbins GT, Chung KA, Hauser RA, Miyasaki JM, Nicholas AP, Poewe W, Seppi K, Rascol O, Stacy MA, Nutt JG, Tanner CM, Urkowitz A, Jaglin JA, Ge S

Caffeine consumption and risk of dyskinesia in CALM-PD.

Movement disorders : official journal of the Movement Disorder Society

Wills AM, Eberly S, Tennis M, Lang AE, Messing S, Togasaki D, Tanner CM, Kamp C, Chen JF, Oakes D, McDermott MP, Schwarzschild MA

Linked clinical trials--the development of new clinical learning studies in Parkinson's disease using screening of multiple prospective new treatments.

Journal of Parkinson's disease

Brundin P, Barker RA, Conn PJ, Dawson TM, Kieburtz K, Lees AJ, Schwarzschild MA, Tanner CM, Isaacs T, Duffen J, Matthews H, Wyse RK

Genetic modification of the association of paraquat and Parkinson's disease.

Movement disorders : official journal of the Movement Disorder Society

Goldman SM, Kamel F, Ross GW, Bhudhikanok GS, Hoppin JA, Korell M, Marras C, Meng C, Umbach DM, Kasten M, Chade AR, Comyns K, Richards MB, Sandler DP, Blair A, Langston JW, Tanner CM

Brain organochlorines and Lewy pathology: the Honolulu-Asia Aging Study.

Movement disorders : official journal of the Movement Disorder Society

Ross GW, Duda JE, Abbott RD, Pellizzari E, Petrovitch H, Miller DB, O'Callaghan JP, Tanner CM, Noorigian JV, Masaki K, Launer L, White LR

Dopamine transporter imaging is associated with long-term outcomes in Parkinson's disease.

Movement disorders : official journal of the Movement Disorder Society

Ravina B, Marek K, Eberly S, Oakes D, Kurlan R, Ascherio A, Beal F, Beck J, Flagg E, Galpern WR, Harman J, Lang AE, Schwarzschild M, Tanner C, Shoulson I

Penetrance of LRRK2 G2385R and R1628P is modified by common PD-associated genetic variants.

Parkinsonism & related disorders

Wang C, Cai Y, Zheng Z, Tang BS, Xu Y, Wang T, Ma J, Chen SD, Langston JW, Tanner CM, Chan P

A high-density genome-wide association screen of sporadic ALS in US veterans.

PloS one

Kwee LC, Liu Y, Haynes C, Gibson JR, Stone A, Schichman SA, Kamel F, Nelson LM, Topol B, Van den Eeden SK, Tanner CM, Cudkowicz ME, Grasso DL, Lawson R, Muralidhar S, Oddone EZ, Schmidt S, Hauser MA

Meta-analysis of Parkinson's disease: identification of a novel locus, RIT2.

Annals of neurology

Pankratz N, Beecham GW, DeStefano AL, Dawson TM, Doheny KF, Factor SA, Hamza TH, Hung AY, Hyman BT, Ivinson AJ, Krainc D, Latourelle JC, Clark LN, Marder K, Martin ER, Mayeux R, Ross OA, Scherzer CR, Simon DK, Tanner C, Vance JM, Wszolek ZK, Zabetian CP, Myers RH, Payami H, Scott WK, Foroud T

Head injury, a-synuclein Rep1, and Parkinson's disease.

Annals of neurology

Goldman SM, Kamel F, Ross GW, Jewell SA, Bhudhikanok GS, Umbach D, Marras C, Hauser RA, Jankovic J, Factor SA, Bressman S, Lyons KE, Meng C, Korell M, Roucoux DF, Hoppin JA, Sandler DP, Langston JW, Tanner CM

Pre-motor features of Parkinson's disease: the Honolulu-Asia Aging Study experience.

Parkinsonism & related disorders

Ross GW, Abbott RD, Petrovitch H, Tanner CM, White LR

Solvent exposures and Parkinson disease risk in twins.

Annals of neurology

Goldman SM, Quinlan PJ, Ross GW, Marras C, Meng C, Bhudhikanok GS, Comyns K, Korell M, Chade AR, Kasten M, Priestley B, Chou KL, Fernandez HH, Cambi F, Langston JW, Tanner CM

Web-based genome-wide association study identifies two novel loci and a substantial genetic component for Parkinson's disease.

PLoS genetics

Do CB, Tung JY, Dorfman E, Kiefer AK, Drabant EM, Francke U, Mountain JL, Goldman SM, Tanner CM, Langston JW, Wojcicki A, Eriksson N

Predictors of time to requiring dopaminergic treatment in 2 Parkinson's disease cohorts.

Movement disorders : official journal of the Movement Disorder Society

Marras C, McDermott MP, Marek K, Rochon P, Naglie G, Tanner CM, Rudolph A, Shoulson I, Lang AE

Rotenone, paraquat, and Parkinson's disease.

Environmental health perspectives

Tanner CM, Kamel F, Ross GW, Hoppin JA, Goldman SM, Korell M, Marras C, Bhudhikanok GS, Kasten M, Chade AR, Comyns K, Richards MB, Meng C, Priestley B, Fernandez HH, Cambi F, Umbach DM, Blair A, Sandler DP, Langston JW

Neuropsychological Profile of Parkin Mutation Carriers with and without Parkinson Disease: The CORE-PD Study.

Journal of the International Neuropsychological Society : JINS

Caccappolo E, Alcalay RN, Mejia-Santana H, Tang MX, Rakitin B, Rosado L, Louis ED, Comella CL, Colcher A, Jennings D, Nance MA, Bressman S, Scott WK, Tanner CM, Mickel SF, Andrews HF, Waters C, Fahn S, Cote LJ, Frucht S, Ford B, Rezak M, Novak K, Friedman JH, Pfeiffer RF, Marsh L, Hiner B, Siderowf AD, Ross BM, Verbitsky M, Kisselev S, Ottman R, Clark LN, Marder KS

Familial aggregation of Parkinson's disease in a multiethnic community-based case-control study.

Movement disorders : official journal of the Movement Disorder Society

Shino MY, McGuire V, Van Den Eeden SK, Tanner CM, Popat R, Leimpeter A, Bernstein AL, Nelson LM

Exploring the electrocardiogram as a potential tool to screen for premotor Parkinson's disease.

Movement disorders : official journal of the Movement Disorder Society

Valappil RA, Black JE, Broderick MJ, Carrillo O, Frenette E, Sullivan SS, Goldman SM, Tanner CM, Langston JW

Cancer incidence in a trial of an antiapoptotic agent for Parkinson's disease.

Movement disorders : official journal of the Movement Disorder Society

Schwid SR, Bausch J, Oakes D, Schuchter L, Tanner C, Forrest M, Lang AE, Shoulson I

Comorbid cancer in Parkinson's disease.

Movement disorders : official journal of the Movement Disorder Society

Lo RY, Tanner CM, Van Den Eeden SK, Albers KB, Leimpeter AD, Nelson LM

Frequency of known mutations in early-onset Parkinson disease: implication for genetic counseling: the consortium on risk for early onset Parkinson disease study.

Archives of neurology

Alcalay RN, Caccappolo E, Mejia-Santana H, Tang MX, Rosado L, Ross BM, Verbitsky M, Kisselev S, Louis ED, Comella C, Colcher A, Jennings D, Nance MA, Bressman SB, Scott WK, Tanner C, Mickel S, Andrews H, Waters C, Fahn S, Cote L, Frucht S, Ford B, Rezak M, Novak K, Friedman JH, Pfeiffer R, Marsh L, Hiner B, Siderowf A, Ottman R, Marder K, Clark LN

Late-life hemoglobin and the incidence of Parkinson's disease.

Neurobiology of aging

Abbott RD, Ross GW, Tanner CM, Andersen JK, Masaki KH, Rodriguez BL, White LR, Petrovitch H

Teaching program for the Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale: (MDS-UPDRS).

Movement disorders : official journal of the Movement Disorder Society

Goetz CG, Stebbins GT, Chmura TA, Fahn S, Poewe W, Tanner CM

Predictors of parkin mutations in early-onset Parkinson disease: the consortium on risk for early-onset Parkinson disease study.

Archives of neurology

Marder KS, Tang MX, Mejia-Santana H, Rosado L, Louis ED, Comella CL, Colcher A, Siderowf AD, Jennings D, Nance MA, Bressman S, Scott WK, Tanner CM, Mickel SF, Andrews HF, Waters C, Fahn S, Ross BM, Cote LJ, Frucht S, Ford B, Alcalay RN, Rezak M, Novak K, Friedman JH, Pfeiffer RF, Marsh L, Hiner B, Neils GD, Verbitsky M, Kisselev S, Caccappolo E, Ottman R, Clark LN

Self-report of cognitive impairment and mini-mental state examination performance in PRKN, LRRK2, and GBA carriers with early onset Parkinson's disease.

Journal of clinical and experimental neuropsychology

Alcalay RN, Mejia-Santana H, Tang MX, Rakitin B, Rosado L, Ross B, Verbitsky M, Kisselev S, Louis ED, Comella CL, Colcher A, Jennings D, Nance MA, Bressman S, Scott WK, Tanner C, Mickel SF, Andrews HF, Waters CH, Fahn S, Cote LJ, Frucht SJ, Ford B, Rezak M, Novak K, Friedman JH, Pfeiffer R, Marsh L, Hiner B, Siderowf A, Ottman R, Clark LN, Marder KS, Caccappolo E

Reliability and validity of two self-administered questionnaires for screening restless legs syndrome in population-based studies.

Sleep medicine

Popat RA, Van Den Eeden SK, Tanner CM, Kushida CA, Rama AN, Black JE, Bernstein A, Kasten M, Chade A, Leimpeter A, Cassidy J, McGuire V, Nelson LM

Advances in environmental epidemiology.

Movement disorders : official journal of the Movement Disorder Society

Tanner CM

Motor phenotype of LRRK2 G2019S carriers in early-onset Parkinson disease.

Archives of neurology

Alcalay RN, Mejia-Santana H, Tang MX, Rosado L, Verbitsky M, Kisselev S, Ross BM, Louis ED, Comella CL, Colcher A, Jennings D, Nance MA, Bressman S, Scott WK, Tanner C, Mickel SF, Andrews HF, Waters CH, Fahn S, Cote LJ, Frucht SJ, Ford B, Rezak M, Novak K, Friedman JH, Pfeiffer R, Marsh L, Hiner B, Siderowf A, Caccappolo E, Ottman R, Clark LN, Marder KS

Urate as a predictor of the rate of clinical decline in Parkinson disease.

Archives of neurology

Ascherio A, LeWitt PA, Xu K, Eberly S, Watts A, Matson WR, Marras C, Kieburtz K, Rudolph A, Bogdanov MB, Schwid SR, Tennis M, Tanner CM, Beal MF, Lang AE, Oakes D, Fahn S, Shoulson I, Schwarzschild MA

Clinical features in early Parkinson disease and survival.

Archives of neurology

Lo RY, Tanner CM, Albers KB, Leimpeter AD, Fross RD, Bernstein AL, McGuire V, Quesenberry CP, Nelson LM, Van Den Eeden SK

A longitudinal program for biomarker development in Parkinson's disease: a feasibility study.

Movement disorders : official journal of the Movement Disorder Society

Ravina B, Tanner C, Dieuliis D, Eberly S, Flagg E, Galpern WR, Fahn S, Goetz CG, Grate S, Kurlan R, Lang AE, Marek K, Kieburtz K, Oakes D, Elliott R, Shoulson I

Occupation and risk of parkinsonism: a multicenter case-control study.

Archives of neurology

Tanner CM, Ross GW, Jewell SA, Hauser RA, Jankovic J, Factor SA, Bressman S, Deligtisch A, Marras C, Lyons KE, Bhudhikanok GS, Roucoux DF, Meng C, Abbott RD, Langston JW

Bowel movement frequency in late-life and substantia nigra neuron density at death.

Movement disorders : official journal of the Movement Disorder Society

Petrovitch H, Abbott RD, Ross GW, Nelson J, Masaki KH, Tanner CM, Launer LJ, White LR

Research priorities in spasmodic dysphonia.

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery

Ludlow CL, Adler CH, Berke GS, Bielamowicz SA, Blitzer A, Bressman SB, Hallett M, Jinnah HA, Juergens U, Martin SB, Perlmutter JS, Sapienza C, Singleton A, Tanner CM, Woodson GE

Nicotine and Parkinson's disease: implications for therapy.

Movement disorders : official journal of the Movement Disorder Society

Quik M, O'Leary K, Tanner CM

Meeting report: consensus statement-Parkinson's disease and the environment: collaborative on health and the environment and Parkinson's Action Network (CHE PAN) conference 26-28 June 2007.

Environmental health perspectives

Bronstein J, Carvey P, Chen H, Cory-Slechta D, DiMonte D, Duda J, English P, Goldman S, Grate S, Hansen J, Hoppin J, Jewell S, Kamel F, Koroshetz W, Langston JW, Logroscino G, Nelson L, Ravina B, Rocca W, Ross GW, Schettler T, Schwarzschild M, Scott B, Seegal R, Singleton A, Steenland K, Tanner CM, Van Den Eeden S, Weisskopf M

Predictors of deterioration in health-related quality of life in Parkinson's disease: results from the DATATOP trial.

Movement disorders : official journal of the Movement Disorder Society

Marras C, McDermott MP, Rochon PA, Tanner CM, Naglie G, Lang AE

Association of olfactory dysfunction with risk for future Parkinson's disease.

Annals of neurology

Ross GW, Petrovitch H, Abbott RD, Tanner CM, Popper J, Masaki K, Launer L, White LR

Potential outcome measures and trial design issues for multiple system atrophy.

Movement disorders : official journal of the Movement Disorder Society

May S, Gilman S, Sowell BB, Thomas RG, Stern MB, Colcher A, Tanner CM, Huang N, Novak P, Reich SG, Jankovic J, Ondo WG, Low PA, Sandroni P, Lipp A, Marshall FJ, Wooten F, Shults CW

Bowel movement frequency in late-life and incidental Lewy bodies.

Movement disorders : official journal of the Movement Disorder Society

Abbott RD, Ross GW, Petrovitch H, Tanner CM, Davis DG, Masaki KH, Launer LJ, Curb JD, White LR

Effect of non-steroidal anti-inflammatory medications on the risk of amyotrophic lateral sclerosis.

Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases

Popat RA, Tanner CM, van den Eeden SK, Bernstein AL, Bloch DA, Leimpeter A, McGuire V, Nelson LM

G2019S mutation in the leucine-rich repeat kinase 2 gene is not associated with multiple system atrophy.

Movement disorders : official journal of the Movement Disorder Society

Ozelius LJ, Foroud T, May S, Senthil G, Sandroni P, Low PA, Reich S, Colcher A, Stern MB, Ondo WG, Jankovic J, Huang N, Tanner CM, Novak P, Gilman S, Marshall FJ, Wooten GF, Chelimsky TC, Shults CW

Epidemiology of Parkinson's disease.

Handbook of clinical neurology

Kasten M, Chade A, Tanner CM

Parkin gene variations and parkinsonism: association does not imply causation.

Annals of neurology

Langston JW, Tanner CM, Schüle B

Association of olfactory dysfunction with incidental Lewy bodies.

Movement disorders : official journal of the Movement Disorder Society

Ross GW, Abbott RD, Petrovitch H, Tanner CM, Davis DG, Nelson J, Markesbery WR, Hardman J, Masaki K, Launer L, White LR

Lack of replication of thirteen single-nucleotide polymorphisms implicated in Parkinson's disease: a large-scale international study.

The Lancet. Neurology

Elbaz A, Nelson LM, Payami H, Ioannidis JP, Fiske BK, Annesi G, Carmine Belin A, Factor SA, Ferrarese C, Hadjigeorgiou GM, Higgins DS, Kawakami H, Krüger R, Marder KS, Mayeux RP, Mellick GD, Nutt JG, Ritz B, Samii A, Tanner CM, Van Broeckhoven C, Van Den Eeden SK, Wirdefeldt K, Zabetian CP, Dehem M, Montimurro JS, Southwick A, Myers RM, Trikalinos TA

Effect of reproductive factors and postmenopausal hormone use on the risk of amyotrophic lateral sclerosis.

Neuroepidemiology

Popat RA, Van Den Eeden SK, Tanner CM, Bernstein AL, Bloch DA, Leimpeter A, McGuire V, Nelson LM

Head injury and Parkinson's disease risk in twins.

Annals of neurology

Goldman SM, Tanner CM, Oakes D, Bhudhikanok GS, Gupta A, Langston JW

Structural variants in the vesicular monoamine transporter do not contribute to sporadic Parkinson's disease.

Movement disorders : official journal of the Movement Disorder Society

Glatt C, Almonte M, Taylor T, Edwards RH, Freimer N, Tanner C

Quality of life in Essential Tremor Questionnaire (QUEST): development and initial validation.

Parkinsonism & related disorders

Tröster AI, Pahwa R, Fields JA, Tanner CM, Lyons KE

Verification of self-report of zygosity determined via DNA testing in a subset of the NAS-NRC twin registry 40 years later.

Twin research and human genetics : the official journal of the International Society for Twin Studies

Reed T, Plassman BL, Tanner CM, Dick DM, Rinehart SA, Nichols WC

High-dosage vitamin E supplementation and all-cause mortality.

Annals of internal medicine

Marras C, Lang AE, Oakes D, McDermott MP, Kieburtz K, Shoulson I, Tanner CM, Fahn S

Smell identification ability in twin pairs discordant for Parkinson's disease.

Movement disorders : official journal of the Movement Disorder Society

Marras C, Goldman S, Smith A, Barney P, Aston D, Comyns K, Korell M, Langston JW, Ross GW, Tanner CM

A responsive outcome for Parkinson's disease neuroprotection futility studies.

Annals of neurology

Elm JJ, Goetz CG, Ravina B, Shannon K, Wooten GF, Tanner CM, Palesch YY, Huang P, Guimaraes P, Kamp C, Tilley BC, Kieburtz K

Non-linearity of Parkinson's disease progression: implications for sample size calculations in clinical trials.

Clinical trials (London, England)

Guimaraes P, Kieburtz K, Goetz CG, Elm JJ, Palesch YY, Huang P, Ravina B, Tanner CM, Tilley BC

Levodopa and the progression of Parkinson's disease.

The New England journal of medicine

Fahn S, Oakes D, Shoulson I, Kieburtz K, Rudolph A, Lang A, Olanow CW, Tanner C, Marek K

Parkinsonian signs and substantia nigra neuron density in decendents elders without PD.

Annals of neurology

Ross GW, Petrovitch H, Abbott RD, Nelson J, Markesbery W, Davis D, Hardman J, Launer L, Masaki K, Tanner CM, White LR

Marked variation in clinical presentation and age of onset in a family with a heterozygous parkin mutation.

Movement disorders : official journal of the Movement Disorder Society

Tan LC, Tanner CM, Chen R, Chan P, Farrer M, Hardy J, Langston JW

Incidence of Parkinson's disease: variation by age, gender, and race/ethnicity.

American journal of epidemiology

Van Den Eeden SK, Tanner CM, Bernstein AL, Fross RD, Leimpeter A, Bloch DA, Nelson LM

Benefits and risks of pharmacological treatments for essential tremor.

Drug safety

Lyons KE, Pahwa R, Comella CL, Eisa MS, Elble RJ, Fahn S, Jankovic J, Juncos JL, Koller WC, Ondo WG, Sethi KD, Stern MB, Tanner CM, Tintner R, Watts RL

Plantation work and risk of Parkinson disease in a population-based longitudinal study.

Archives of neurology

Petrovitch H, Ross GW, Abbott RD, Sanderson WT, Sharp DS, Tanner CM, Masaki KH, Blanchette PL, Popper JS, Foley D, Launer L, White LR

Impact of sustained deprenyl (selegiline) in levodopa-treated Parkinson's disease: a randomized placebo-controlled extension of the deprenyl and tocopherol antioxidative therapy of parkinsonism trial.

Annals of neurology

Shoulson I, Oakes D, Fahn S, Lang A, Langston JW, LeWitt P, Olanow CW, Penney JB, Tanner C, Kieburtz K, Rudolph A